Fri, Nov 21, 2014, 5:45 AM EST - U.S. Markets open in 3 hrs 45 mins


% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

  • bioimmunomabman bioimmunomabman Mar 25, 2013 10:46 AM Flag

    IMGN performance

    I recall selling all of my clients' IMGN stock at $20+ back in 1991 when I was a young stock broker and many old time followers have seen their stock range from $2-$40+. 22 years later and the stock is lower. IMGN seems to only create wealth for the execs, not for the shareholders. The market value is up, but the stock price is not. IMGN is not keeping pace with the biotech ETF's/indices or with the closest rival SGEN. A much younger entrant ECYT has gone from $4 to $11 in the past year while IMGN has done nothing. Someone needs to go to the meeting and represent the shareholders and ask the BOD some tough questions about IMGN's poor overall and relative performance.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
9.68+0.37(+3.97%)Nov 20 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Splunk, Inc.
NasdaqGSThu, Nov 20, 2014 4:00 PM EST
Aruba Networks, Inc.
NasdaqGSThu, Nov 20, 2014 4:00 PM EST